Table 3.

Proportions of patients undergoing osteoporosis treatment in high-risk group according to the high-risk of fracture in FRAX and osteoporosis by the WHO criteria.

Variable (patient groups), n	High-risk in FRAX with BMD	High-risk in FRAX without BMD	Osteoporosis by the WHO criteria
Overall	12/25 (48%)	16/24 (66.7%)	35/51 (68.6%)
Premenopausal	4/5 (80%)	3/3 (100%)	5/8 (62.5%)
Postmenopausal	8/20 (40%)	13/21 (61.9%)	30/43 (69.8%)
Bisphosphonate therapy	9/25 (36.0%)	15/24 (62.5%)	26/51 (51%)

Values are presented as number (%).

FRAX: fracture risk assessment tool, BMD: bone mineral density, WHO: World Health Organization.